NCT07140510View on ClinicalTrials.gov

Dinalbuphine Sebacate in Postoperative Pain Control After TKA

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 31, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

September 30, 2026

Conditions
Osteo Arthritis of the KneeTotal Knee Anthroplasty
Interventions
DRUG

Dinalbuphine Sebacate

Dinalbuphine Sebacate 150 mg intramuscular injection after spinal anesthesia and adductor canal block in the same side of TKA

DRUG

Normal Saline

Normal saline 2 mL intramuscular injection after spinal anesthesia and adddutor canal block

Trial Locations (1)

12120

Thammasat University, Khlong Luang

All Listed Sponsors
lead

Thammasat University

OTHER